Last reviewed · How we verify

NCT04955860

Evaluation of First Molar Inclinations and Transverse Arch Width in Individuals With Posterior Crossbite

Completed Last updated 16 July 2021
What this trial tests

trial testing Dental model analysis in Crossbite (Anterior) (Posterior) in 120 participants. Completed in 1 July 2021.

Timeline
20 March 2020
Primary endpoint
20 March 2021
1 July 2021

Quick facts

Lead sponsorTC Erciyes University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment120
Start date20 March 2020
Primary completion20 March 2021
Estimated completion1 July 2021
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

TC Erciyes University

Who can join

Adults 12 to 18, any sex, with Crossbite (Anterior) (Posterior) or Dental Malocclusion. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to evaluate and compare the inclination of the lower and upper permanent first molars and the transversal width of the lower and upper jaws in individuals of different age groups to evaluate whether the existing anomaly at different ages in individuals with a bilateral posterior crossbite. For this reason, first molar tooth inclination and lower and upper jaw transversal width will be evaluated in adolescent and post-adolescent individuals with a bilateral posterior crossbite.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Evaluation of First Molar Buccolingual Angulations and Dental Arch Parameters in Adolescents with Bilateral Posterior Crossbite.
    Öztürk T, Yağcı A, Ramoğlu Sİ. · · 2023 · PMID 37781999 · DOI 10.4274/turkjorthod.2022.2022.59

Verify or expand the search:

Other TC Erciyes University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04955860.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing